SEC Company Response from Artemis Therapeutics, Inc. (MNKA) (CIK 0001062128) — Nov 28, 2005
Artemis Therapeutics, Inc. (MNKA) (CIK 0001062128)
Date: Nov. 28, 2005 · CIK: 0001062128 · Accession: 0001178913-05-001667
AI Filing Summary & Sentiment
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
INKSURE TECHNOLOGIES INC.
1770 N.W. 64th Street
Fort Lauderdale, Florida 33309
November 28, 2005
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Mail Stop 7010
Washington, DC 20549
Attention: John Cash
Accounting Branch Chief
RE: INKSURE TECHNOLOGIES INC.
FORM 10-KSB FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004
FILE NO. 0-24431
Dear Mr. Cash:
Reference is made to your letter, dated November 15, 2005 (the "Comment
Letter"), regarding the Inksure Technologies Inc. (the "Company") Form 10-KSB
for the fiscal year ended December 31, 2004. Our response is set forth below the
comment you provided in the Comment Letter, which for convenience, we have
incorporated into this response letter.
LOCATION OF AUDITOR
We note that your audit report was signed by an audit firm based in Israel.
Please tell us how you concluded that it is appropriate to have an audit
report issued by an auditor licensed outside of the United States, in light
of the fact that more than 50% of your assets are located outside of
Israel; the majority of your revenues are derived outside of Israel, and
your executive offices are located in the United States. In accordance with
Article 2 of Regulation S-X, we believe that the audit report of a
registrant (that is not a foreign private issuer) should ordinarily be
rendered by an auditor licensed in the United States. Further guidance may
be found in Section 5.K of "International Reporting and Disclosure Issues
in the Division of Corporation Finance" on the Commission's website at:
http://www.sec.gov/divisions/corpfin/internatl/cfirdissues1104.htm. Please
tell us if you currently have plans to employ an audit firm located in the
United States to render an opinion for fiscal 2005. If not, please tell us
whether your management and accounting records are located in the United
States or Israel as well as where the majority of the audit work is
conducted. We may have further comments.
<PAGE>
Securities and Exchange Commission
November 28, 2005
Page 2
WE CONCLUDED THAT IT IS APPROPRIATE TO HAVE AN AUDIT REPORT ISSUED BY AN
AUDITOR BASED IN ISRAEL FOR THE FOLLOWING REASONS:
o OUR CHIEF FINANCIAL OFFICER AND OUR CHIEF OPERATING OFFICER ARE
LOCATED IN ISRAEL, AND UNTIL MAY 2005, OUR CHIEF EXECUTIVE OFFICER WAS
LOCATED IN ISRAEL. IN MAY 2005, WE DIVIDED THE RESPONSIBILITIES OF THE
CHIEF EXECUTIVE OFFICER BETWEEN THE CHIEF EXECUTIVE OFFICER AND THE
CHIEF OPERATING OFFICER. AT THAT TIME, OUR CHAIRMAN OF THE BOARD, WHO
IS NOW LOCATED IN THE UNITED STATES, WAS APPOINTED CHIEF EXECUTIVE
OFFICER, PRINCIPALLY TO HELP OUR MARKETING EFFORTS IN THE UNITED
STATES. SALES AND MARKETING EFFORTS IN THE INTERNATIONAL MARKET REMAIN
THE RESPONSIBILITY OF THE CHIEF OPERATING OFFICER, TOGETHER WITH
RESEARCH AND DEVELOPMENT AND PRODUCTION RESPONSIBILITIES.
o OUR CHIEF FINANCIAL OFFICER, BOOKKEEPING STAFF AND ACCOUNTING RECORDS
ARE LOCATED IN ISRAEL. FURTHERMORE, ALL OF OUR CUSTOMER INVOICES ARE
GENERATED IN ISRAEL. ACCORDINGLY, THE MAJORITY OF OUR AUDIT WORK IS
CONDUCTED IN ISRAEL.
o WE HAVE 20 EMPLOYEES, 13 OF WHICH ARE LOCATED IN ISRAEL.
o ALL OF OUR RESEARCH AND DEVELOPMENT ACTIVITIES ARE PERFORMED IN
ISRAEL, AS WELL AS THE MAJORITY OF OUR PRODUCTION ACTIVITIES. THE
REMAINDER OF OUR PRODUCTION ACTIVITIES ARE PERFORMED BY A
SUBCONTRACTOR IN THE UNITED STATES, BUT SUCH ACTIVITIES ARE ALSO
CONTROLLED FROM ISRAEL.
o OUR OPERATING SUBSIDIARY IN THE UNITED STATES IS SOLELY A SALES AND
MARKETING UNIT OF OUR ISRAELI OPERATIONS.
o THE MAJORITY OF OUR FIXED ASSETS AND ALL OF OUR INVENTORY IS LOCATED
IN ISRAEL.
o 60% OF OUR OPERATING EXPENSES ARE GENERATED IN ISRAEL.
WE DO NOT CURRENTLY HAVE PLANS TO EMPLOY AN AUDIT FIRM LOCATED IN THE UNITED
STATES TO RENDER AN OPINION FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005.
As you requested in the Comment Letter, we hereby acknowledge as follows:
a. the Company is responsible for the adequacy and accuracy of the
disclosures in their filings;
b. Staff comments, or changes to disclosures in response to Staff
comments, do not foreclose the Securities and Exchange Commission (the
"Commission") from taking any action with respect to the filing; and
<PAGE>
Securities and Exchange Commission
November 28, 2005
Page 3
c. the Company may not assert Staff comments as a defense in any
proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
Please call the undersigned at (212) 362-5764 with any comments or
questions and please send a copy of any additional comments or correspondence to
Kenneth R. Koch, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., 666
Third Avenue, 25th Floor, New York, NY 10017.
Very truly yours,
/s/ Elie Housman
----------------
Elie Housman
Chief Executive Officer
cc: Eyal Bigon, Chief Financial Officer
Inksure Technologies Inc.
Kenneth R. Koch, Esq.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
</TEXT>
</DOCUMENT>